全文获取类型
收费全文 | 341018篇 |
免费 | 9116篇 |
国内免费 | 493篇 |
专业分类
耳鼻咽喉 | 3510篇 |
儿科学 | 11934篇 |
妇产科学 | 7596篇 |
基础医学 | 39556篇 |
口腔科学 | 6168篇 |
临床医学 | 23440篇 |
内科学 | 69002篇 |
皮肤病学 | 6234篇 |
神经病学 | 29994篇 |
特种医学 | 12660篇 |
外国民族医学 | 31篇 |
外科学 | 50102篇 |
综合类 | 3144篇 |
一般理论 | 42篇 |
预防医学 | 34933篇 |
眼科学 | 6126篇 |
药学 | 21398篇 |
中国医学 | 1173篇 |
肿瘤学 | 23584篇 |
出版年
2023年 | 867篇 |
2022年 | 1310篇 |
2021年 | 3773篇 |
2020年 | 1965篇 |
2019年 | 3657篇 |
2018年 | 26397篇 |
2017年 | 20037篇 |
2016年 | 22221篇 |
2015年 | 4383篇 |
2014年 | 5389篇 |
2013年 | 7528篇 |
2012年 | 17042篇 |
2011年 | 31107篇 |
2010年 | 24220篇 |
2009年 | 16318篇 |
2008年 | 27743篇 |
2007年 | 30333篇 |
2006年 | 9480篇 |
2005年 | 11067篇 |
2004年 | 11662篇 |
2003年 | 11983篇 |
2002年 | 9844篇 |
2001年 | 5556篇 |
2000年 | 5848篇 |
1999年 | 4717篇 |
1998年 | 1485篇 |
1997年 | 1136篇 |
1996年 | 959篇 |
1995年 | 843篇 |
1994年 | 731篇 |
1992年 | 2313篇 |
1991年 | 2256篇 |
1990年 | 2148篇 |
1989年 | 1866篇 |
1988年 | 1680篇 |
1987年 | 1629篇 |
1986年 | 1503篇 |
1985年 | 1461篇 |
1984年 | 1069篇 |
1983年 | 921篇 |
1979年 | 1013篇 |
1978年 | 681篇 |
1975年 | 692篇 |
1974年 | 915篇 |
1973年 | 867篇 |
1972年 | 750篇 |
1971年 | 698篇 |
1970年 | 777篇 |
1969年 | 735篇 |
1968年 | 691篇 |
排序方式: 共有10000条查询结果,搜索用时 296 毫秒
41.
42.
Spontaneous generation of functional osteoclasts from synovial fluid mononuclear cells as a model of inflammatory osteoclastogenesis
下载免费PDF全文
![点击此处可从《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Stinne R. Greisen Halldór Bjarki Einarsson Malene Hvid Ellen‐Margrethe Hauge Bent Deleuran Tue Wenzel Kragstrup 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2015,123(9):779-786
In osteoimmunology, osteoclastogenesis is understood in the context of the immune system. Today, the in vitro model for osteoclastogenesis necessitates the addition of recombinant human receptor activator of nuclear factor kappa‐B ligand (RANKL) and macrophage colony‐stimulating factor (M‐CSF). The peripheral joints of patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA) are characterized by an immune‐mediated inflammation that can lead to bone destruction. Here, we evaluate spontaneous in vitro osteoclastogenesis in cultures of synovial fluid mononuclear cells (SFMCs) activated only in vivo. SFMCs were isolated and cultured for 21 days at 0.5–1.0 × 106 cells/mL in culture medium. SFMCs and healthy control peripheral blood monocytes were cultured with RANKL and M‐CSF as controls. Tartrate‐resistant acid phosphatase (TRAP) positive multinucleated cells were found in the SFMC cultures after 21 days. These cells expressed the osteoclast genes calcitonin receptor, cathepsin K, and integrin β3, formed lacunae on dentin plates and secreted matrix metalloproteinase 9 (MMP9) and TRAP. Adding RANKL and M‐CSF potentiated this secretion. In conclusion, we show that SFMCs from inflamed peripheral joints can spontaneously develop into functionally active osteoclasts ex vivo. Our study provides a simple in vitro model for studying inflammatory osteoclastogenesis. 相似文献
43.
44.
Henry Havel Gregory Finch Pamela Strode Marc Wolfgang Stephen Zale Iulian Bobe Hagop Youssoufian Matthew Peterson Maggie Liu 《The AAPS journal》2016,18(6):1373-1378
Advancing nanomedicines from concept to clinic requires integration of new science with traditional pharmaceutical development. The medical and commercial success of nanomedicines is greatly facilitated when those charged with developing nanomedicines are cognizant of the unique opportunities and technical challenges that these products present. These individuals must also be knowledgeable about the processes of clinical and product development, including regulatory considerations, to maximize the odds for successful product registration. This article outlines these topics with a goal to accelerate the combination of academic innovation with collaborative industrial scientists who understand pharmaceutical development and regulatory approval requirements—only together can they realize the full potential of nanomedicines for patients. 相似文献
45.
46.
47.
M. Alexandra Friedman Charlotte M. Niznik Janelle R. Bolden Lynn M. Yee 《Journal of community health》2016,41(2):354-358
While peer support has been investigated in multiple clinical contexts, its application to the postpartum setting is unknown. The aim was to assess acceptability of a postpartum peer support program for women with diabetes. Observational survey-based needs assessment of forty low-income women with diabetes, receiving care at a major medical institution. Mean age and gravidity were 30.7 years and 3.15 ± 1.67 respectively. 45 % expressed interest in a “buddy.” There was no significant difference between groups desiring and not desiring this program. A majority of respondents desired telephone, text messaging, and in-person contacts (79.2, 72.1, 83.8 %), with 72.5 % of patients desiring diabetes-related activities during clinic waiting time. Many women desire a postpartum diabetes reciprocal peer program for support outside of clinician visits. Patients are receptive to educational services during their wait and outside of clinic time, a potentially valuable opportunity to share important health information. 相似文献
48.
49.
50.
José Antonio Pereira Miguel Pera Manuel López-Cano Marta Pascual Sandra Alonso Silvia Salvans Marta Jiménez-Toscano Alba González-Martín Luis Grande-Posa 《Cirugía espa?ola》2019,97(1):20-26